Allgens Medical Technology CO., LTD. (SHA:688613)

Market Cap	2.69B -22.8%
Revenue (ttm)	227.76M +10.7%
Net Income	8.62M
EPS	0.06
Shares Out	137.01M
PE Ratio	311.90
Forward PE	n/a
Dividend	0.03 (0.15%)
Ex-Dividend Date	Aug 6, 2026

Volume	7,705,497
Open	19.63
Previous Close	19.62
Day's Range	19.42 - 20.75
52-Week Range	12.94 - 29.77
Beta	0.59
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 31, 2026

About SHA:688613

Allgens Medical Technology CO., LTD. engages in the research and development, production, and sale of biomedical materials and related medical device products in China. The company offers biomimetic mineralized collagen artificial bone repair products, including Gejin, Chibei, and Lurui, as well as Aoyu Ning; tissue regeneration and repair products; and absorbable collagen hemostatic sponge products. Its products include isometal, cranial ulcer, teeth, dental implants, and bongold. The company was founded in 2004 and is based in Beijing, China.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2004
• Employees: 271
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688613

Financial Performance

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 29, 2026

Data Sources Report a data error